title: The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye.
abstract: Dry eye is a common, multifactorial disease currently diagnosed by a combination of symptoms and signs. However, the subjective symptoms of dry eye poorly correlate to the current gold standard for diagnostic tests, reflecting the need to develop better objective tests for the diagnosis of dry eye. This review considers the role of ocular surface matrix metalloproteinase 9 (MMP-9) in dry eye and the implications of a novel point-of-care test that measures MMP-9 levels, InflammaDry (RPS, Sarasota, FL) on choosing appropriate therapeutic treatments.
authors: Miami Veterans Administration Medical Center, Miami, FL, USA; Ocular Surface Center Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.
authors: Nicole L
authors: NL
authors: Lanza
authors: Ocular Surface Center Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.
authors: Felipe
authors: F
authors: Valenzuela
authors: Ocular Surface Center Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. Electronic address: vperez4@med.miami.edu.
authors: Victor L
authors: VL
authors: Perez
authors: Miami Veterans Administration Medical Center, Miami, FL, USA; Ocular Surface Center Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. Electronic address: agalor@med.miami.edu.
authors: Anat
authors: A
authors: Galor
mesh_terms: D015352:Dry Eye Syndromes; D005123:Eye; D006801:Humans; D007638:Keratoconjunctivitis Sicca; D020780:Matrix Metalloproteinase 9; D019095:Point-of-Care Systems
chemical_list: D020780:Matrix Metalloproteinase 9
keywords: InflammaDry; dry eye; matrix metalloproteinase 9